Both tirzepatide and semaglutide follow a structured, step-up dosing approach designed to help the body adjust gradually while reducing the risk of side effects
Visit facilities if possible or request audits
Also known as: MT-1, MT1, Melanotan I, MT-I, Afamelanotide, Scenesse, NDP-alpha-MSH, CUV1647 Photoprotection and skin tanning via MC1R agonism (approved as afamelanotide for EPP) Amount 0.16 mg/kg daily (injection protocol)
For patients experiencing persistent issues, temporary treatment interruption may be necessary while electrolytes are corrected and hydration restored, followed by reinitiation at a lower dose with more gradual titration
This may translate into improved recovery following exercise, greater potential for muscle hypertrophy, and more effective connective tissue remodeling
These include, in alphabetical order: Diabetic retinopathy: This can happen in people who have type 2 diabetes, possibly because of the dramatic impact Wegovy can have in improving glucose control